New nanoparticle drug aims to fight tough lung cancer
Disease control
Recruiting now
This study tests a new drug called SNB-101, a nanoparticle version of a chemotherapy agent, in people with extensive stage small cell lung cancer that has progressed after standard treatment. The trial has two phases: phase 1 checks safety and the best dose, while phase 2 looks a…
Phase: PHASE1, PHASE2 • Sponsor: SN BioScience • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC